Sjögren's syndrome-associated interstitial lung disease: A multicenter study

Reumatol Clin. Jul-Aug 2016;12(4):201-5. doi: 10.1016/j.reuma.2015.09.003. Epub 2015 Nov 11.
[Article in En, Spanish]

Abstract

Primary Sjögren syndrome (PSS) is a chronic inflammatory autoimmune disease. Interstitial lung disease (ILD) can be an extraglandular complication.

Objective: To evaluate the clinical characteristics of patients diagnosed with PSS with ILD.

Methods: Multicentre cohort study with 25 patients diagnosed with PSS and ILD. Data of PSS, prognostic factors, pulmonary involvement variables, complementary tests that suggest a worse diagnosis and treatment given were collected. EULAR index was measured for Sjögren's syndrome.

Results: We identified 25 patients. In 15/25 the diagnosis of ILD was done before the diagnosis of PSS. The histopathological patterns found were: 12 NSIP, 5 UIP, 4 OP, 2 LIP. PFRs showed restrictive pattern. The majority of the patients received glucocorticoid therapy, antimalarial or immunosuppressive treatment.

Conclusions: Patients affected with PSS must be screened to catch a precocious diagnosis of ILD. The majority of the patients were diagnosed of ILD before being diagnosed of PSS. Multicenter cohorts are increasingly demanded and a multidisciplinary management is needed.

Keywords: Enfermedad pulmonar intersticial; Interstitial lung disease; Sjögren syndrome; Síndrome de Sjögren.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / etiology*
  • Lung Diseases, Interstitial / pathology
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Sjogren's Syndrome / complications*
  • Sjogren's Syndrome / diagnosis
  • Sjogren's Syndrome / pathology